The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A first-in-human phase 1 trial of dose escalating intrathecal (IT) dendritic cells (cDC1s) primed against HER2/HER3 in patients (pts) with leptomeningeal disease (LMD) from triple-negative (TNBC) or HER2+ breast cancer (BC).
 
Peter A. J. Forsyth
Honoraria - Abbvie; BTG; Novocure; Stanford University Health, Department of Neurology
Consulting or Advisory Role - Abbvie; Boehringer Ingelheim; Boehringer Ingelheim; Bristol-Myers Squibb; BTG; Midatech Pharma; National Brain Tumor Society; Novartis; Novocure; Tocagen; ZIOPHARM Oncology
Research Funding - Bankhead-Coley Cancer Research; Bristol-Myers Squibb; Department of Defense; Florida Academic Cancer Center Alliance; Florida Breast Cancer Foundation; MSCCoE; NIH/NCI; Pfizer
Travel, Accommodations, Expenses - Abbvie; Bayer; Bristol-Myers Squibb; BTG; Inovio Pharmaceuticals; National Cancer Research Institute (NCRI); NCCN; NCI; NIH; Physical Sciences Oncology Network
 
Shipra Gandhi
Honoraria - Aptitude Health; OncLive/MJH Life Sciences
Consulting or Advisory Role - AstraZeneca; Hologic/Biotheranostics; MedPage Today; Novartis
 
Jessica Wilcox
No Relationships to Disclose
 
Vincent Law
No Relationships to Disclose
 
Qianxing Mo
No Relationships to Disclose
 
Zhihua Chen
No Relationships to Disclose
 
Kamran A. Ahmed
Honoraria - Bristol-Myers Squibb; Cancer Network; Castle Biosciences
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst)
 
Cecily Piteo
No Relationships to Disclose
 
Brittany Evernden
No Relationships to Disclose
 
Yolanda Pina
No Relationships to Disclose
 
Adrienne Ann Boire
Consulting or Advisory Role - Apellis Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Boire A and J Massagué, inventors. Sloan Kettering Institute, assignee. Modulating Permeability Of The Blood Cerebrospinal Fluid Barrier. United States Provisional Application No.: 62/258,044. November 20, 2015. (Inst); Boire A, Chen Q and J Massagué, inventors. Sloan Kettering Institute, assignee. Methods for Treating Brain Metastasis. United States 10413522, awarded September 17, 2019. (Inst); Boire A, inventor. Sloan Kettering Institute, assignee. Methods of Treating Leptomeningeal Metastasis. United States Provisional Application No.: 63/052,139. Jul 15, 2020 (Inst)
(OPTIONAL) Uncompensated Relationships - Evren Technologies
 
Pawel Kalinski
Consulting or Advisory Role - Ikena Oncology2-3 yrs ago)
Research Funding - Ikena Boston), not related to any presentations at ASCOI
Patents, Royalties, Other Intellectual Property - Northwest Bio (active licensing discussions) Not related to any presentation at ASCO
 
Brian J. Czerniecki
Honoraria - Merit Medical Systems
Speakers' Bureau - Merit Medical Systems
Patents, Royalties, Other Intellectual Property - I+munoRestoration